Yanping Hu

机构：FIND, Hubei Cancer Hospital, The University of Texas Medical Branch at Galveston · ORCID：0000-0001-7128-2648

发表论文 212 篇 · 总被引 5139 次 · h-index 32

代表论文

• Genomic analysis of 1,325 Camellia accessions sheds light on agronomic and metabolic traits for tea plant improvement (2025 · Nature Genetics · 被引 42)
• First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 7)
• Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases (2026 · JAMA · 被引 5)
• Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial (2025 · Translational Lung Cancer Research · 被引 5)
• Abstract CT053: Aumolertinib with or without chemotherapy as first line treatment in locally advanced or metastatic NSCLC with sensitizing EGFR mutations (AENEAS2) (2025 · Cancer Research · 被引 4)
• Effect of Massage on Regulating Oxidative Stress in Intervertebral Disc Degeneration in a Rat Model (2025 · Journal of Manipulative and Physiological Therapeutics · 被引 3)